13th Mar 2019 15:36
LONDON (Alliance News) - 4d Pharma PLC on Wednesday said Non-Executive Chair David Norwood and Non-Executive Director Thomas Engelen both purchased shares in the AIM-listed pharmaceutical company.
In separate transaction on Tuesday, Norwood bought 23,725 shares at a price of 82.36 pence each, worth GBP19,540, and Engelen acquired 4,800 shares at 85p each, totalling GBP4,080.
Shares in 4d Pharma were trading 9.4% higher on Wednesday at 94.00p each.
Related Shares:
DDDD.L